Cohort profile: cholangiocarcinoma screening and care program (CASCAP)-Reference-Cited by-同舟云学术

Cohort profile: cholangiocarcinoma screening and care program (CASCAP)

Published:2015-06-09 Issue:1 Volume:15 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Khuntikeo Narong, ,Chamadol Nittaya,Yongvanit Puangrat,Loilome Watcharin,Namwat Nisana,Sithithaworn Paiboon,Andrews Ross H.,Petney Trevor N.,Promthet Supannee,Thinkhamrop Kavin,Tawarungruang Chaiwat,Thinkhamrop Bandit

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/article/10.1186/s12885-015-1475-7/fulltext.html

Reference29 articles.

1. Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology. 2004;66(3):167–79.

2. Yao D, Kunam VK, Li X. A review of the clinical diagnosis and therapy of cholangiocarcinoma. J Int Med Res. 2014;42(1):3–16.

3. Zeng X, Tao H. Diagnostic and prognostic serum marker of cholangiocarcinoma (review). Oncol Letters. 2015;9(1):3–8.

4. Khan SA, Emadossadaty S, Ladep NG, Thomas HC, Elliott P, Taylor-Robinson SD, et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol. 2012;56(4):848–54.

5. Bertuccio P, Bosetti C, Levi F, Decarli A, Negri E, La Vecchia C. A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe. Annals Oncol Off J European Soc Med Oncol ESMO. 2013;24(6):1667–74.

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese national clinical practice guideline on diagnosis and treatment of biliary tract cancers;Chinese Medical Journal;2024-09-04

2. Antitumor Activity of Tasurgratinib as an Orally Available FGFR1-3 Inhibitor in Cholangiocarcinoma Models With FGFR2-fusion;Anticancer Research;2024-05-31

3. Spatial analysis of cholangiocarcinoma in relation to diabetes mellitus and Opisthorchis viverrini infection in Northeast Thailand;Scientific Reports;2024-05-07

4. Current and Future Therapeutic Targets for Directed Molecular Therapies in Cholangiocarcinoma;Cancers;2024-04-26

5. Early-Onset Gastrointestinal Malignancies: An Investigation into a Rising Concern;Cancers;2024-04-18